Paul Moayyedi
Overview
Explore the profile of Paul Moayyedi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
361
Citations
13122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bernstein C, Nugent Z, Panaccione R, Marshall D, Kaplan G, Dieleman L, et al.
J Clin Gastroenterol
. 2025 Jan;
PMID: 39853241
Background: We aimed to examine the relationship between disease symptoms and disease phenotype in a large Canadian cohort of persons with Crohn's disease (CD). Methods: Adults (n=1515) with CD from...
2.
3.
Ford A, Yuan Y, Park J, Forman D, Moayyedi P
Gastroenterology
. 2025 Jan;
PMID: 39824392
Background And Aims: Screening for, and treating, Helicobacter pylori in the general population or patients with early gastric neoplasia could reduce incidence of, and mortality from, gastric cancer. We updated...
4.
Armstrong D, Hungin A, Kahrilas P, Sifrim D, Moayyedi P, Vaezi M, et al.
Aliment Pharmacol Ther
. 2024 Dec;
61(4):636-650.
PMID: 39740235
Background: Many patients diagnosed with gastro-oesophageal reflux disease (GERD) have persistent symptoms despite proton pump inhibitor (PPI) therapy. Aims: The aim of this consensus is to provide evidence-based statements to...
5.
Kao D, Wong K, Jijon H, Moayyedi P, Franz R, McDougall C, et al.
Am J Gastroenterol
. 2024 Nov;
PMID: 39530534
Introduction: Fecal microbiota transplantation (FMT) has shown promise at inducing remission in ulcerative colitis. This study is the first of its kind to evaluate the efficacy and safety of FMT...
6.
Olson J, Palumbo A, Desjardins C, Wicks C, Bhopa S, Cheyne K, et al.
BMJ Open
. 2024 Nov;
14(11):e089220.
PMID: 39521469
Introduction: Digital health tools can be beneficial in the care of patients with chronic conditions and have the potential for widespread impact as readily scalable and cost-effective health interventions. However,...
7.
Kawano-Dourado L, Kristianslund E, Zeraatkar D, Jani M, Makharia G, Hazlewood G, et al.
BMJ
. 2024 Oct;
387:e079830.
PMID: 39467592
Clinical Question: In adult patients with inflammatory bowel disease, inflammatory arthritis (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis), or psoriasis taking biologic drugs, does proactive therapeutic drug monitoring (TDM) improve outcomes as...
8.
Lee S, Bushra M, Qiu L, Shao J, Olivera P, Leibovitzh H, et al.
Gastroenterology
. 2024 Oct;
168(2):385-388.e3.
PMID: 39384162
No abstract available.
9.
Patel A, Laine L, Moayyedi P, Wu J
Gastroenterology
. 2024 Sep;
167(6):1228-1238.
PMID: 39269391
Description: The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update (CPU) is to summarize the available evidence and offer expert Best Practice Advice on the integration of...
10.
Olivera P, Martinez-Lozano H, Leibovitzh H, Xue M, Neustaeter A, Espin-Garcia O, et al.
Gastroenterology
. 2024 Sep;
168(1):99-110.e2.
PMID: 39236898
Background & Aims: Unaffected first-degree relatives (FDRs) from families with ≥2 affected FDRs with Crohn's disease (CD, multiplex families) have a high risk of developing CD, although the underlying mechanisms...